These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 8590439

  • 1. Plasma lipids and lipoprotein alterations in tamoxifen-treated breast cancer women in relation to the menopausal status.
    Ilanchezhian S, Thangaraju M, Sachdanandam P.
    Cancer Biochem Biophys; 1995 Nov; 15(2):83-90. PubMed ID: 8590439
    [Abstract] [Full Text] [Related]

  • 2. Ameliorating effect of coenzyme Q10, riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins.
    Yuvaraj S, Premkumar VG, Vijayasarathy K, Gangadaran SG, Sachdanandam P.
    Clin Biochem; 2007 Jun; 40(9-10):623-8. PubMed ID: 17425952
    [Abstract] [Full Text] [Related]

  • 3. Effects of toremifene and tamoxifen on lipid profiles in post-menopausal patients with early breast cancer: interim results from a Japanese phase III trial.
    Tominaga T, Kimijima I, Kimura M, Takatsuka Y, Takashima S, Nomura Y, Kasumi F, Yamaguchi A, Masuda N, Noguchi S, Eshima N.
    Jpn J Clin Oncol; 2010 Jul; 40(7):627-33. PubMed ID: 20382637
    [Abstract] [Full Text] [Related]

  • 4. Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status.
    Vehmanen L, Elomaa I, Blomqvist C, Saarto T.
    J Clin Oncol; 2006 Feb 01; 24(4):675-80. PubMed ID: 16446340
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of anastrozole and tamoxifen on lipid metabolism in Japanese postmenopausal women with early breast cancer.
    Sawada S, Sato K, Kusuhara M, Ayaori M, Yonemura A, Tamaki K, Hiraide H, Mochizuki H, Ohsuzu F.
    Acta Oncol; 2005 Feb 01; 44(2):134-41. PubMed ID: 15788292
    [Abstract] [Full Text] [Related]

  • 7. Effects of toremifene (TOR) and tamoxifen (TAM) on serum lipids in postmenopausal patients with breast cancer.
    Kusama M, Miyauchi K, Aoyama H, Sano M, Kimura M, Mitsuyama S, Komaki K, Doihara H.
    Breast Cancer Res Treat; 2004 Nov 01; 88(1):1-8. PubMed ID: 15538040
    [Abstract] [Full Text] [Related]

  • 8. Augmented antioxidant status in Tamoxifen treated postmenopausal women with breast cancer on co-administration with Coenzyme Q10, Niacin and Riboflavin.
    Yuvaraj S, Premkumar VG, Vijayasarathy K, Gangadaran SG, Sachdanandam P.
    Cancer Chemother Pharmacol; 2008 May 01; 61(6):933-41. PubMed ID: 17668211
    [Abstract] [Full Text] [Related]

  • 9. [Effects of tamoxifen and estrogen replacement therapy on lipid metabolism and some other cardiovascular risk factors. A prospective study in hysterectomised women].
    Imperato F, Marziani R, Perniola G, Ebano V, Fruscella M, Mossa B.
    Minerva Ginecol; 2003 Feb 01; 55(1):87-93. PubMed ID: 12598849
    [Abstract] [Full Text] [Related]

  • 10. Comparative assessment of lipid effects of endocrine therapy for breast cancer: implications for cardiovascular disease prevention in postmenopausal women.
    Esteva FJ, Hortobagyi GN.
    Breast; 2006 Jun 01; 15(3):301-12. PubMed ID: 16230014
    [Abstract] [Full Text] [Related]

  • 11. Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: Results from a controlled randomised trial.
    Alkner S, Bendahl PO, Fernö M, Nordenskjöld B, Rydén L, South Swedish and South-East Swedish Breast Cancer Groups.
    Eur J Cancer; 2009 Sep 01; 45(14):2496-502. PubMed ID: 19535242
    [Abstract] [Full Text] [Related]

  • 12. Effect of tamoxifen on measurements of hemostasis in healthy women.
    Mannucci PM, Bettega D, Chantarangkul V, Tripodi A, Sacchini V, Veronesi U.
    Arch Intern Med; 1996 Sep 09; 156(16):1806-10. PubMed ID: 8790074
    [Abstract] [Full Text] [Related]

  • 13. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS, Costantino JP, Cummings SR, Wickerham DL, Vogel VG, Dowsett M, Folkerd EJ, Willett WC, Wolmark N, Hankinson SE.
    J Natl Cancer Inst; 2006 Jan 18; 98(2):110-5. PubMed ID: 16418513
    [Abstract] [Full Text] [Related]

  • 14. Effect of tamoxifen on GH and IGF-1 serum level in stage I-II breast cancer patients.
    Mandalà M, Moro C, Ferretti G, Calabro MG, Nolè F, Rocca A, Munzone E, Castro A, Curigliano G.
    Anticancer Res; 2001 Jan 18; 21(1B):585-8. PubMed ID: 11299809
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Studies on the changes in plasma lipids and lipoproteins in CMF treated breast cancer patients.
    Subramaniam S, Marar T, Devi CS.
    Biochem Int; 1991 Aug 18; 24(6):1015-24. PubMed ID: 1781779
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.